Immunobiology of hepatitis C virus (HCV) infection: The roleof CD4 T-cell in HCV infection

Immunological Reviews

Volumn 174, Issue , 2000, Pages 90-97

  Eckels, David D ^a   Wang, Huiru ^a   Bian, Tong Hua ^a   Tabatabai, Niloofar ^a   Gill, Joan C ^a  

^a BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; EPITOPE; GAMMA INTERFERON; HLA ANTIGEN CLASS 2; INTERLEUKIN 10; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA; VIRUS ANTIBODY; VIRUS ANTIGEN;

ANTIVIRAL ACTIVITY; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMORAL IMMUNITY; IMMUNOBIOLOGY; IMMUNOPATHOGENESIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VIRUS GENOME; VIRUS MUTATION;

ANTIGEN PRESENTATION; ANTIGENIC VARIATION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; HEPACIVIRUS; HEPATITIS C; HEPATITIS, CHRONIC; HLA-D ANTIGENS; HUMANS; KILLER CELLS, NATURAL; LIVER; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COOPERATION; LYMPHOCYTE SUBSETS; MUTATION;

EID: 0034037613     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0528.2002.017403.x     Document Type: Review

References (54)

1. 1. Brodsky FM. Stealth, sabotage and exploitation. Immunol Rev 1999;168:5-11.
2. 2. Eckels DD, Flomenberg P, Gill JC. Hepatitis C virus: models of immunopathogenesis and prophylaxis. Transfusion 1996;36:836-844.
3. 3. McMichael A. T cell responses and viral escape. Cell 1998;93:673-676.
4. 4. Cooper S, et al. Analysis of a successful immune response against hepatitis C virus. Immunity 1999;10:439-449.
5. 5. Sourdive DJ, et al. Conserved T cell receptor repertoire in primary and memory CD8 T cell responses to an acute viral infection. J Exp Med 1998;188:71-82.
6. 6. Napoli J, Bishop GA, McGuinness PH, Painter DM, McCaughan GW. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 1996;24:759-765.
7. 7. O'Farrelly C, Cripse IN. Prometheus through the looking glass: reflections on the hepatic immune system. Immunol Today 1999;24:394-398.
8. 8. Pileri P, et al. Binding of hepatitis C virus to CD81. Science 1998;282:938-941.
9. 9. Eckels DD, et al. In vitro human Th-cell responses to a recombinant hepatitis C virus antigen: failure in IL-2 production despite proliferation. Hum Immunol 1999;60:187-199.
10. 10. Cacciarelli TV, Martinez OM, Gish RG, Villanueva JC, Krams SM. Immunoregulatory cytokines in chronic hepatitis C virus infection: pre-and post-treatment with interferon α. Hepatology 1996;24:6-9.
11. 11. Reiser M, et al. Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection. J Hepatol 1997;26:471-478.
12. 12. Tsai SL, Liaw YF, Chen MH, Huang CY, Kuo GC. Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology 1997;25:449-458.
13. 13. Woitas RP, Lechmann M, Jung G, Kaiser R, Sauerbruch T, Spengler U. CD30 induction and cytokine profiles in hepatitis C virus core-specific peripheral blood T lymphocytes. J Immunol 1997;159:1012-1018.
14. 14. Koziel MJ. Immunology of viral hepatitis. Am J Med 1996;100:98-109.
15. 15. Wong DKH, et al. Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection. J Immunol 1998;160:1479-1488.
16. 16. Chang KM, et al. Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus. J Clin Invest 1997;100:2376-1385.
17. 17. Botarelli P, et al. T-lymphocyte responses to hepatitis C virus in different courses of infection. Gastroenterology 1993;104:580-587.
18. 18. Shimizu YK, Hijikata M, Iwamoto A, Alter HJ, Purcell RH, Yoshikura H. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol 1994;68:1494-1500.
19. 19. Panuska JR, et al. Respiratory syncytial virus induces interleukin-10 by human alveolar macrophages. Suppression of early cytokine production and implications for incomplete immunity. J Clin Invest 1995;96:2445-2453.
20. 20. Bouffard P, Hayashi PH, Acevedo R, Levy N, Zeldis JB. Hepatitis C virus is detected in a monocyte/macrophage subpopulation of peripheral blood mononuclear cells of infected patients. J Infect Dis 1992;166:1276-1280.
21. 21. Shimizu YK, Iwamoto A, Hijikata M, Purcell RH, Yoshikura H. Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line. Proc Natl Acad Sci USA 1992;89:5477-5481.
22. 22. Ferri C, et al. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood 1993;82:3701-3704.
23. 23. Zignego AL, et al. Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol 1992;15:382-386.
24. 24. Moldvay J, Deny P, Pol S, Brechot C, Lamas E. Detection of hepatitis C virus RNA in peripheral blood mononuclear cells of infected patients by in situ hybridization. Blood 1994;83:269-273.
25. 25. Hill AV. The immunogenetics of human infectious diseases. Annu Rev Immunol 1999;16:593-617.
26. 26. Congia M, et al. HLA class II genes in chronic hepatitis C virus-infection and associated immunological disorders. Hepatology 1996;24:1338-1341.
27. 27. Cramp ME, Carucci P, Underhill J, Naoumov NV, Williams R, Donaldson PT. Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia. J Hepatol 1998;29:207-213.
28. 28. Tibbs C, Donaldson P, Underhill J, Thomson L, Manabe K, Williams R. Evidence that the HLA DQA1*03 allele confers protection from chronic HCV - infection in northern European caucasoids. Hepatology 1996;24:1342-1345.
29. 29. Zavaglia C, et al. Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C. J Hepatol 1998;28:1-7.
30. 30. Barrett S, Ryan E, Crowe J. Association of the HLA-DRB1*01 allele with spontaneous viral clearance in an Irish cohort infected with hepatitis C virus via contaminated anti-D immunoglobulin. J Hepatol 1999;30:979-983.
31. 31. Alric L, et al. Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection. Gastroenterology 1997;113:1675-1681.
32. 32. Minton EJ, Smillie D, Neal KR, Irving WL, Underwood JC, James V. Association between MHC class II alleles and clearance of circulating hepatitis C virus. Members of the Trent Hepatitis C Virus Study Group. J Infect Dis 1998;178:39-44.
33. 33. Bertoletti A, et al. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 1994;369:407-410.
34. 34. Tsai SL, et al. Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity. Gastroenterol 1998;115:954-966.
35. 35. Kaneko T, et al. Impaired induction of cytotoxic T lymphocytes by antagonism of a weak agonist borne by a varaint hepatitis C virus epitope. Eur J Immunol 1997;27:1782-1787.
36. 36. Meier UC, et al. Cytotoxic T lymphocyte lysis inhibited by viable HIV mutants. Science 1995;270:1360-1362.
37. 37. Cerny A, Chisari FV. Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology 1999;30:595-601.
38. + cytotoxic T cell clones. J Immunol 1989;142:2847-2854.
39. 39. Guidotti LG, Chisari FV. Cytokine-induced viral purging-role in viral pathogenesis. Curr Opin Microbiol 1999;2:388-391.
40. 40. Guidotti LG, Borrow P, Brown A, McClary H, Koch R, Chisari FV. Noncytopathic clearance of lymphocytic choriomeningitis virus from the hepatocyte. J Exp Med 1999;189:1555-1564.
41. 41. Franco A, Guidotti LG, Hobbs MV, Pasquetto V, Chisari FV. Pathogenetic effector function of CD4-positive T helper 1 cells in hepatitis B virus transgenic mice. J Immunol 1997;159:2001-2008.
42. + T cells. J Immunol 1999;163:650-658.
43. 43. De Magistris MT, Alexander J, Coggeshall M, Altman A, Gaeta FCA, Sette A. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell 1992;68:625-634.
44. 44. Sloan-Lancaster J, Evavold BD, Allen PM. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature 1993;363:156-159.
45. 45. Tabatabai N, Bian TH, Rice CM, Yoshizawa K, Gill J, Eckels DD. Functionally distinct T-cell epitopes within the hepatitis C virus non-structural 3 protein. Hum Immunol 1999;60:105-115.
46. 46. Wang H, Eckels DD. Mutations in immunodominant T cell epitopes derived from the non-structural 3 protein of hepatitis C virus have the potential for generating escape variants that may have important consequences for T cell recognition. J Immunol 1999;162:4177-4183.
47. 47. Eckels DD, Zhou H, Bian TH, Wang H. Identification of antigenic escape variants in an immunodominant epitope of hepatitis C virus. Int Immunol 1999;11:577-583.
48. 48. Moore KW, O'Garra A, de Waal MR, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993;11:165-190.
49. 49. Lundberg KS, Shoemaker DD, Adams MWW, Short JM, Sorge JA, Mathur EJ. High-fidelity amplification using a thermostable DNA polymerase isolated from Pyrococcus furiosus. Gene 1991;108:1-6.
50. 50. Barnes WM. The fidelity of Taq polymerase catalyzing PCR is improved by an N-terminal deletion. Gene 1992;112:29-35.
51. 51. Smith DB, McAllister J, Casino C, Simmonds P. Virus 'quasispecies': making a mountain out of a molehill? J Gen Virol 1997;78:1511-1519.
52. 52. Hughes A, Nei M. Nucleotide substitution at major histocompatibility complex class II loci: evidence for overdominant selection. Proc Natl Acad Sci USA 1989;86:958-962.
53. 53. Martin MJ, Nunez JI, Sobrino F, Dopazo J. A procedure for detecting selection in highly variable viral genomes: evidence of positive selection in antigenic regions of capsid protein VP1 of foot-and-mouth disease virus. J Virol Methods 1998;74:215-221.
54. 54. Grakoui A, Wychowski C, Lin C, Feinstone SM, Rice CM. Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol 1993;67:1385-1395.